demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
non-steroidal anti-inflammatory drugs
Indomethacin Ravichandran

2 studies excluded by filtering options 0

6361 Ravichandran, 2020 1100not a RCTrisk of bias not avaialble
9250 Guzman-Esquivel, 2022 000selection pending